Sitryx Therapeutics logo

Sitryx Therapeutics jobs and careers

Oxford, England, United Kingdom

About Sitryx Therapeutics

Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation.

Founded in 2018 by Houman Ashrafian, Jeff Rathmell, Jonathan Powell, Luke O'Neill, Michael Rosenblum and Paul-Peter Tak.

Founded
2018
Employees
11 to 50
Total funding
$79M
Headquarters
Oxford

Leadership

The top of Sitryx Therapeutics's org chart, with how many people report into each leader.

NWPhoto of Neil Weir

Neil Weir

CEO

14 reports

RRPhoto of Ravi Rao

Ravi Rao

CMO

8 reports

AMPhoto of Adam Mostafa

Adam Mostafa

Chief Financial Officer

1 report

BSPhoto of Ben Stephens

Ben Stephens

Chief Operating Officer

1 report

FIPhoto of Fiona Irvine

Fiona Irvine

Head, People & Culture

Board

KBPhoto of Kate Bingham

Kate Bingham

Board Member

BRPhoto of Brad Robling

Brad Robling

Board Member

PTPhoto of Paul-Peter Tak

Paul-Peter Tak

Board Member

RPPhoto of Rab Prinjha

Rab Prinjha

Board Member

NTPhoto of Nikola Trbovic

Nikola Trbovic

Board Member

MBPhoto of Maina Bhaman

Maina Bhaman

Director